Financials
Financial year 2025
ERANOV PHARMA from Mouscron, company number BE0738849394, closed financial year 2025 with a result of € 10,757 after tax. For that financial year ERANOV PHARMA recorded a gross margin of € 33,805 and equity of € 88,753. Compared with financial year 2024, the result moved from € -2,887 to € 10,757. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 18, 2026.
€ 88,753
▲ 14% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 10,757
▲ still € 2,887 loss in 2024
Profit after tax over the fiscal year.
€ 111
▼ 25% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 86,753.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
€ 563
▼ 57% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 4,053
Loans from banks and other lenders, long and short.
€ 35,347
▲ 35% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 17,440
▲ 170% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Revenue | € 119,443 | - | - | - | |
| Gross margin | € 33,405 | € 25,143 | € 2,949 | € 33,805 | ▲ € 30,855 |
| Profit after taxes | € 24,265 | € 16,316 | € -2,887 | € 10,757 | ▲ € 13,644 |
| Equity | € 64,567 | € 80,883 | € 77,996 | € 88,753 | ▲ 14% |
| Total debts | € 83,430 | € 34,241 | € 33,971 | € 64,341 | ▲ 89% |
| Cash | € 6,026 | € 4,442 | € 148 | € 111 | ▼ 25% |
| Retained profit | € 62,567 | € 78,883 | € 75,996 | € 86,753 | ▲ 14% |
| Bank debt | € 0 | € 0 | € 0 | € 4,053 | |
| Balance sheet total | € 147,997 | € 115,124 | € 111,967 | € 153,094 | ▲ 37% |
Key figures of ERANOV PHARMA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to ERANOV PHARMA?
What happened at ERANOV PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 10,757. Source: NBB ↗
- New establishment in Ath. KBO
- Paul AKAHI KOMENAN Saint became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 24,265 profit in 2022 to € 10,757 profit in 2025.
Paid € 21,553 in corporate taxes since 2022.
Best year ever: 2022, with € 24,265 profit.
A new publication or filing at ERANOV PHARMA? We notify you, reason included.
Follow ERANOV PHARMADatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind ERANOV PHARMA is Paul AKAHI KOMENAN Saint.
Directors
According to the 2025 annual accounts
Paul AKAHI KOMENAN Saint
Director
since 2019
Establishments
Establishment units
Physical locations of this company
Jean Jaurèslaan 118
7700 Mouscron
Rue de Messine 42 box 11
7800 Ath
Active since 9 December 2019
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0738.849.394
- VAT number
- BE 0738.849.394
- Registered office
- Jean Jaurèslaan 118, 7700 Mouscron
- Names & denominations
- ERANOV PHARMA
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 9 December 2019
- Peppol
- Active · Active since 1 Jan 2001
- Activities · NACE
Overige activiteiten van vrije beroepen en andere wetenschappelijke en technische activiteiten, neg
Overige gespecialiseerde wetenschappelijke en technische activiteiten
Overige zakelijke dienstverlening, neg